Latest Conference Articles

A poster presented at ACG provides an updated analysis of clostridium difficile infection in the tofacitinib UC clinical program.

Sulindac and eflornithine could help delay the need for lower gastrointestinal surgery for FAP patients.

New data presented at ACG 2020 shows NER1006 bowel preparation to be safe and efficacious in patients with diabetes preparing for their colonoscopy.

Researchers test 3 different doses of mirikizumab in both biologic experienced and naïve Crohn’s disease patients.

An expert discusses a study assessing the effects of low compliance to eosinophilic esophagitis therapies among pediatric patients.

Ustekinumab resulted in a reduction of both stool frequency and rectal bleeding for ulcerative colitis patients.

New research shows patients with chronic liver disease admitted for influenza had an increased risk of disease severity but not a higher odds of mortality.

More than half of the patient population achieved a defined response at both day 14 and week 6.

Research shows dupilumab remains effective in EoE for up to 2 years.

A new study presented at ACG shows vedolizumab to be superior to adalimumab in maintaining early disease control in patients with moderate-to-severe ulcerative colitis.

In data presented at ACG, investigators found a link between sex, lower BMI, and the development of irritable bowel syndrome in patients following a c. diff infection.

In a poster presented during ACG, investigators show data from a long-term extension of the UNIFI trial.

Patients with chronic pancreatitis can exhibit dependence on chronic opioid therapy prior to receiving total pancreatectomy with islet autotransplantation.

Isolation as a result of suspected C. Diff can take a significant financial toll on the healthcare system, thus it is necessary to determine appropriate factors that can predict CDI.

An expert discusses the difficulties in diagnosing and managing myositis, as well as how the COVID-19 pandemic has affected clinical care.

Three key issues with using the technology over in-person visits.

Care of rheumatic patients must factor in cradiovascular risk and conditions.

The recently published American College of Rheumatology guidelines on reproductive health is a great resource for rheumatologists.

How rheumatologists use telemedicine during COVID-19.

Leveraging telemedicine during COVID-19.

An expert discusses the role of the rheumatologist in managing cardiovascular risk factors as well as current gaps in the field.

An expert explains resources for pain related to rheumatic conditions.

MIS-C is a condition recently recognized in children with COVID-19.

Rheumatologists and OB-GYNs must communicate openly with each other and to patients with rheumatic diseases who are considering pregnancy.

An expert discusses the state of screening, diagnosing, and treating osteoarthritis and osteoporosis.

Which composite measures detect the highest level of changes in psoriatic disease activity.

In the MONARCH OLE study, more than 50% of patients with rheumatoid arthritis who had low or inadequate response to adalimumab and switched to sarilumab experienced an improvement in disease activity.

Patient assessments measured fatigue, disease activity, global spinal pain, and spinal pain at night.

How providers of multiple specialists can come together to help 1 patient.

An expert dermatologist explains.